Jeffrey Morris Miller

Jeffrey Morris Miller

Auto-generated profile, based on publicly available information

Jeffrey Morris Miller

Molecular Imaging and Neuropathology Area, New York State Psychiatric Institute, New York, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2010 in Biological Psychiatry
Verified
Journal Article
Closed access
RPRamin V. Parsey
Ramin V. Parsey
ROR. Todd Ogden
R. Todd Ogden
JMJeffrey M. Miller
Jeffrey M. Miller
ATAdrienne Tin
Adrienne Tin
NHNatalie Hesselgrave
Natalie Hesselgrave
JMJ. John Mann
J. John Mann

1 February 2015 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
GSGregory M. Sullivan
Gregory M. Sullivan
MOMaria A. Oquendo
Maria A. Oquendo
MMMatthew Milak
Matthew Milak
JMJeffrey M. Miller
Jeffrey M. Miller
ABAinsley Burke
Ainsley Burke
JMJ. John Mann
J. John Mann
Suicide claimed the lives of more than 38 000 individuals in the United States in 2010.1 Although the majority of suicides occur in the setting of a current psychiatric disorder, most commonly major depressive disorder (MDD),2 most individuals with MDD never attempt suicide. Of those who do, fewer make higher-lethality attempts, confounding efforts to detect and mitigate suicide risk. Thus, an urgent need exists for in vivo biomarkers of suicide risk to assist clinical identification and management of such high-risk patients.

13 March 2009 in Synapse
Verified
Journal Article
Closed access
PDF file
JMJeffrey M. Miller
Jeffrey M. Miller
EKErin L. Kinnally
Erin L. Kinnally
ROR. Todd Ogden
R. Todd Ogden
MOMaria A. Oquendo
Maria A. Oquendo
JMJ. John Mann
J. John Mann
RPRamin V. Parsey
Ramin V. Parsey

1 August 2013 in Biological Psychiatry
Verified
Journal Article
Closed access
JMJeffrey M. Miller
Jeffrey M. Miller
NHNatalie Hesselgrave
Natalie Hesselgrave
ROR. Todd Ogden
R. Todd Ogden
GSGregory M. Sullivan
Gregory M. Sullivan
MOMaria A. Oquendo
Maria A. Oquendo
RPRamin V. Parsey
Ramin V. Parsey

1 October 2016 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
MOMaria A. Oquendo
Maria A. Oquendo
HGHanga Galfalvy
Hanga Galfalvy
GSGregory M. Sullivan
Gregory M. Sullivan
JMJeffrey M. Miller
Jeffrey M. Miller
MMMatthew M. Milak
Matthew M. Milak
JMJ. John Mann
J. John Mann
Suicidal behavior occurs in the context of a diathesis characterized by impairments in mood and emotion regulation, decision making, problem solving, and social appraisal.1 Suicidal behavior is also associated with specific biomarkers,2 mostly involving the serotonergic system and hypothalamic pituitary adrenal axis. We found individuals with major depressive disorder (MDD) who attempt suicide (attempters) have lower in vivo midbrain serotonin transporter binding compared with those who do not attempt suicide (nonattempters or control individuals),3,4 suggesting that the differences in the proportions of suicide attempters studied may contribute to discrepant positron emission tomography (PET) findings in MDD.5,6 Similarly, attempters with MDD showed lower serotonin transporter binding in the midbrain and pons4 compared with controls. In contrast, a small study using iodine 123–labeled beta [3H]2-beta-carbomethoxy-3-beta-[4'-iodophenyl]tropane7 single-photon emission computed tomography linked higher serotonin transporter binding in the globus pallidus to suicidal behavior. Using fluorodeoxyglucose F 18–labeled PET, a previous investigation8 found attempters with MDD had lower regional rates of cerebral glucose metabolism in the right dorsolateral prefrontal cortex (PFC) compared with nonattempters with MDD, a discrepancy that roughly doubled after fenfluramine administration, which suggested impaired serotonergic response.9 In a serotonin2A binding study using 123I-5-I-R91150 and single-photon emission computed tomography, deliberate self-harming patients who did not use medication had less frontal serotonin2A binding compared with controls. Thus, most studies implicate serotonergic dysfunction in suicidal behavior.

1 November 2013 in Biological Psychiatry
Verified
Journal Article
Closed access
JMJeffrey M. Miller
Jeffrey M. Miller
NHNatalie Hesselgrave
Natalie Hesselgrave
ROR. Todd Ogden
R. Todd Ogden
Francesca ZanderigoFrancesca Zanderigo
Francesca Zanderigo
MOMaria A. Oquendo
Maria A. Oquendo
RPRamin V. Parsey
Ramin V. Parsey